Literature DB >> 16828325

A case of ethylmalonic encephalopathy with atypical clinical and biochemical presentation.

Maja Di Rocco1, Ubaldo Caruso, Egill Briem, Andrea Rossi, Anna E M Allegri, Davide Buzzi, Valeria Tiranti.   

Abstract

A child is reported presenting with a clinical picture suggestive of genetic connective tissue disorders (vascular fragility, articular hyperlaxity, delayed motor development, and normal cognitive development), an absence of pathological ethylmalonic acid excretion during inter-critical phases and a homozygous R163W mutation in the ETHE1 gene. This case suggests that ethylmalonic aciduria is not a constant biochemical marker of ethylmalonic encephalopathy and that its normal excretion outside of metabolic decompensation episodes does not exclude this metabolic disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828325     DOI: 10.1016/j.ymgme.2006.05.010

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  9 in total

1.  Turkish case of ethylmalonic encephalopathy misdiagnosed as short chain acyl-CoA dehydrogenase deficiency.

Authors:  Fatma Derya Bulut; Deniz Kör; Berna Şeker-Yılmaz; Gülen Gül-Mert; Sebile Kılavuz; Neslihan Önenli-Mungan
Journal:  Metab Brain Dis       Date:  2017-11-20       Impact factor: 3.584

2.  Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.

Authors:  Mustafa Kılıç; Özge Dedeoğlu; Rahşan Göçmen; Selman Kesici; Deniz Yüksel
Journal:  Metab Brain Dis       Date:  2016-11-09       Impact factor: 3.584

3.  Knockout of the murine cysteine dioxygenase gene results in severe impairment in ability to synthesize taurine and an increased catabolism of cysteine to hydrogen sulfide.

Authors:  Iori Ueki; Heather B Roman; Alessandro Valli; Krista Fieselmann; Jimmy Lam; Rachel Peters; Lawrence L Hirschberger; Martha H Stipanuk
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-06-21       Impact factor: 4.310

Review 4.  Altered sulfide (H(2)S) metabolism in ethylmalonic encephalopathy.

Authors:  Valeria Tiranti; Massimo Zeviani
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

5.  Ethylmalonic encephalopathy associated with crescentic glomerulonephritis.

Authors:  Imad Dweikat; Enas Naser; Nadera Damsah; Bassam Abu Libdeh; Izzeddin Bakri
Journal:  Metab Brain Dis       Date:  2012-05-15       Impact factor: 3.584

6.  Severe early onset ethylmalonic encephalopathy with West syndrome.

Authors:  Laura Papetti; Giacomo Garone; Livia Schettini; Carla Giordano; Francesco Nicita; Paola Papoff; Massimo Zeviani; Vincenzo Leuzzi; Alberto Spalice
Journal:  Metab Brain Dis       Date:  2015-07-21       Impact factor: 3.584

7.  Cysteine dioxygenase 1 is a tumor suppressor gene silenced by promoter methylation in multiple human cancers.

Authors:  Mariana Brait; Shizhang Ling; Jatin K Nagpal; Xiaofei Chang; Hannah Lui Park; Juna Lee; Jun Okamura; Keishi Yamashita; David Sidransky; Myoung Sook Kim
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

8.  Neurological and Vascular Manifestations of Ethylmalonic Encephalopathy.

Authors:  Ali Reza Tavasoli; Parastoo Rostami; Mahmoud Reza Ashrafi; Parvaneh Karimzadeh
Journal:  Iran J Child Neurol       Date:  2017

9.  Ethylmalonic encephalopathy masquerading as meningococcemia.

Authors:  Zornitza Stark; Michael Fahey; Ari Horton; Kai Mun Hong; Dinusha Pandithan; Meredith Allen; Caroline Killick; Stacy Goergen; Amanda Springer; Dean Phelan; Melanie Marty; Rebecca Halligan; Joy Lee; James Pitt; Belinda Chong; John Christodoulou; Sebastian Lunke
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-03-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.